Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Wave Life Sciences Ltd. - Ordinary Shares
(NQ:
WVE
)
7.260
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Wave Life Sciences Ltd. - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Crude Oil Falls Over 2%; Campbell's Earnings Top Estimates
↗
September 03, 2025
Via
Benzinga
Wednesday's session: gap up and gap down stocks
↗
September 03, 2025
Today's session on Wednesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
Nasdaq Gains Over 100 Points; Dollar Tree Post Upbeat Earnings
↗
September 03, 2025
Via
Benzinga
Which stocks are moving before the opening bell on Wednesday?
↗
September 03, 2025
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.
Via
Chartmill
Earnings Scheduled For July 30, 2025
↗
July 30, 2025
Via
Benzinga
Insights into WAVE Life Sciences's Upcoming Earnings
↗
July 29, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
↗
May 08, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 03, 2025
Via
Benzinga
Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
September 03, 2025
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
August 04, 2025
Via
Benzinga
Beyond The Numbers: 6 Analysts Discuss WAVE Life Sciences Stock
↗
August 04, 2025
Via
Benzinga
WAVE Life Sciences Earnings Preview
↗
May 07, 2025
Via
Benzinga
Wave (WVE) Q2 Revenue Drops 56%
↗
July 31, 2025
Via
The Motley Fool
Wave Life Sciences Ltd (NASDAQ:WVE) Reports Q2 2025 Earnings: Revenue Miss but Narrower Loss and Clinical Progress Boost Shares
↗
July 30, 2025
Wave Life Sciences Q2 2025 results show $8.7M revenue miss but narrower EPS loss. Stock rises on optimism for WVE-006's AATD clinical progress.
Via
Chartmill
Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update
July 30, 2025
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
This MongoDB Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
July 28, 2025
Via
Benzinga
Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025
July 23, 2025
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Breaking Down WAVE Life Sciences: 4 Analysts Share Their Views
↗
July 16, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 10, 2025
Via
Benzinga
Where WAVE Life Sciences Stands With Analysts
↗
June 23, 2025
Via
Benzinga
Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions
June 20, 2025
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference
May 29, 2025
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer
May 28, 2025
Dr. Wright brings deep experience across a wide breadth of therapeutic areas and modalities and will guide clinical development of Wave’s robust RNA medicines pipeline
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update
May 08, 2025
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025
May 01, 2025
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
The Analyst Verdict: WAVE Life Sciences In The Eyes Of 4 Experts
↗
April 29, 2025
Via
Benzinga
Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next Year
↗
March 26, 2025
Wave Life plans a 2026 NDA filing for WVE-N531 after positive Phase 2 data in Duchenne muscular dystrophy, showing functional gains and biomarker improvements.
Via
Benzinga
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531
March 26, 2025
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 04, 2025
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 4, 2025
↗
March 04, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
